Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Solid Tumors × asciminib × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18 Leukemia, Myeloid, Chronic-Phase 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Philadelphia Chromosome 2 Myeloproliferative Disorders 2 Leukemia, Myeloid 2 Leukemia 2 Bronchiolitis Obliterans Syndrome 2 Malignant Solid Tumors 1 Hematologic Diseases 1 HER2+ Metastatic Breast Cancer 1 Burkitt Lymphoma 1 Brain Neoplasms 1 Blast Crisis 1

Interventions

Injections 16 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 Leucovorin 6 Fluorouracil 6 Docetaxel 5 Pemetrexed 4 Paclitaxel 4 Oxaliplatin 4 trifluridine tipiracil drug combination 3 atezolizumab 3 Capecitabine 3 tislelizumab 2 spartalizumab 2 sotorasib 2 palbociclib 2 olaparib 2 fludarabine 2 Panitumumab 2 Irinotecan 2 HMPL-013 2 Fulvestrant 2 Etoposide 2 Drug Therapy 2 Cyclophosphamide 2 Cisplatin 2 Cetuximab 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡